Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors

New Board Member Brings Life Sciences Tools Experience to the Leader in

Cellular Bioenergetic Profiling

Aug 10, 2007, 01:00 ET from Seahorse Bioscience

    N. BILLERICA, Mass., Aug. 10 /PRNewswire/ -- Seahorse Bioscience, the
 leading provider of tools for real-time measurement of cellular
 bioenergetics in microplates, announced today that former Molecular Devices
 executive Joseph Keegan has been appointed to the company's Board of
 Directors. In this position, Keegan will apply his successful business
 experience in the life sciences industry to accelerate the growth of
 Seahorse Bioscience's novel technology for profiling cell metabolism.
     "As the company moves into its next phase of growth, it will require a
 strong understanding of this market," said Jay Teich, Seahorse Bioscience's
 CEO. "Joe's tremendous success in building Molecular Devices, combined with
 his extensive labware experience makes him an ideal addition to our Board."
     Keegan brings more than 25 years of experience managing life science
 tools businesses. As CEO of Molecular Devices, he developed a strategy
 combining internal growth with acquisitions to build the dominant supplier
 of detection solutions for drug discovery, clinical and research
 applications. Keegan joined MDC from Becton Dickinson and Company where he
 served as President of Worldwide Tissue Culture. Prior to Becton Dickinson,
 Keegan was Vice President of Microscopy and Scientific Instruments Division
 of Leica, Inc.
     "Seahorse has developed a 'stethoscope for living cells.' The ability
 to measure cell metabolism in a truly non-invasive way has very broad
 applications," said Keegan. "Drawing on my experience with both instrument
 and labware businesses, I look forward to helping Seahorse grow a
 successful business in a field that I understand very well."
     About Seahorse Bioscience
     Seahorse Bioscience is changing cancer, obesity and diabetes drug
 discovery programs the world over. Seahorse headquarters are located in
 North Billerica, Massachusetts. For more information, please visit
     Media Contact:
     Cheryle Cushion
     Seahorse Bioscience
     (978) 671-1697

SOURCE Seahorse Bioscience